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INTRODUCTION
LASER is an acronym for "Light Amplification by Stimulated Emission of Radiation" and has been widely used in dentistry for more than 30 years. The light produced by laser is powerful as it has three distinctive properties, namely, the light is monochromatic, coherent, and collimated. The first LASER or "Microwave amplification by stimulated emission of radiation (MASER)" was developed by Theodore H. Maiman in the year 1960. Lasers are classified as hard and soft tissue lasers based on the type of laser-tissue interaction and not on the type of tissue exposed. Low-level laser therapy (LLLT) is a form of laser medicine used in physical therapy, which uses low-level lasers or light-emitting diode to alter cellular functions. Low-level laser therapy has various other names like low-power laser, soft tissue lasers, cold lasers, biostimulation laser, therapeutic laser, and laser acupuncture. The average power of laser ranges from 1 to 500 mW and the wavelength ranges from red to near infrared, i.e., 600 to 1000 nm. Whereas high-power lasers ablate tissue, low-power lasers stimulate various tissues and encourage the cells to function. Low-level laser therapy is a noninvasive and painless process that uses photonic energy to provide biological therapeutic advantages, including analgesic effects. It is used in the management of indolent or infected wounds, tissue necrosis, nerve injury, and osteoarthritis or other chronic pain syndromes, such as myofacial pain, fracture healing, tendinous or ligamentous injury, and postsurgical incision care. In dentistry, LLLT is used in the treatment of recurrent aphthous stomatitis (RAS), herpes simplex infections, oral lichen planus, xerostomia, mucositis, paraesthesia, periodontitis, dentinal hypersensitivity, temporomandibular joint disorders (TMD), and pain during orthodontic tooth movement.
MECHANISM OF ACTION
The working of LLLT is vague, but it is shown that it may reduce pain associated with inflammation by lowering the levels of prostaglandin E2 (PGE 2 ), interleukin-1 beta (IL-1 beta), tumor necrosis factor-alpha (TNF-alpha), cellular influx of neutrophils and granulocytes, oxidative stress, edema, and bleeding in a dose-dependent manner. 1 The dosage of LLLT ranges from 0.3 to 19 J/ cm 2 . Low-level laser therapy has a stimulatory effect on cells at low dosage and a suppressive effect at high dosage. Another mechanism proposed is by stimulating the mitochondrion to increase adenosine triphosphate (ATP) production in order to increase the reactive oxygen species (ROS), which in turn, influences redox signaling, affecting intercellular homeostasis of the proliferation of cells. 2 Low-level laser therapy also has an effect on the microcirculation, which reduces edema by changing the capillary hydrostatic pressure. 3 The ideal dose of LLLT leads to the formation of new endothelium and blood 
STIMULATION OF ACTIVITY OF MITOCHONDRION
The capacity of infrared light to stimulate more efficient electron transfer in the cytochrome oxidase pathway is relatively well established. This might be due to the underlying mechanism of action for most of the physiologic effects of LLLT. Cytochrome C oxidase, an enzyme i.e., present in the cellular mitochondrial membrane, plays a key role in ATP synthesis. 4 A part of this enzyme appears to be a chromophore (lightresponsive molecule) that absorbs energy from photons moving on wavelengths in the near infrared spectrum, which accelerates electron transfer rate and further increases the capacity of mitochondria to synthesize ATP. Greater ATP production thus results in increased energy available for the cell's metabolic processes.
EFFECT ON ANGIOGENESIS
The infrared light promotes vascular endothelial development and angiogenesis. 5 This property is significant for both the consideration of tissue healing and when applying laser to highly vascularized tissues. Laser is contraindicated in highly vascular tissues, e.g., neoplasms. Dourado et al 5 reported an increased angiogenesis at different wavelengths (633 and 904 nm) with greater response to 633 nm as compared to 904 nm at lower doses while higher doses of 633 wavelengths appeared to be less effective than 904 nm wavelength. Likewise, Cury et al 6 demonstrated benefit from both 660
and 780 nm but the shorter wavelength was effective only at higher doses and longer wavelength was effective at both high and low doses.
MODULATION OF INFLAMMATION
Low-level laser therapy not only increases the macrophage and neutrophil activity, but they also do so in a way that favorably enhances the output of specific inflammatory mediators. This states that under certain circumstances, laser light may not be a purely nonspecific stimulator of cell metabolism. Briefly, laser inhibits inflammatory catabolic mediators that suppress collagen synthesis and cell proliferation. Low-level laser therapy reduces neutrophil influx into chronically inflamed tissues or fluid-filled spaces and may stimulate production of antiinflammatory metabolites, such as cyclooxygenase 1 (COX-1) and cyclooxygenase 2 (COX-2). Laser also helps in reducing edema, 3 which is an important factor in patient discomfort, and retards nutrient exchange in inflamed tissues. that were irradiated at a dose of 0.5 to 1.5 J/cm 2 with a helium-neon (HeNe) laser and found a significant increase in basic fibroblast growth factor (bFGF) release from both keratinocytes and fibroblasts and a significant increase in nerve growth factor release from keratinocytes. Recently, Akgul et al 17 reported that postponing the onset of LLLT after acute inflammatory phase showed better results. In an animal study by Farouk et al 18 , influence of various laser wavelengths (442, 514, 632, 670, 780, 830, and 10600 nm) on the healing of oval full-thickness wounds in Sprague-Dawley rats was evaluated and the accelerated wound closure was from 7.7 to 29% in healing days. A HeNe laser at a wavelength of 632.8 nm gave the best acceleration in the healing days (29%). This study showed wavelength dependency, treatment schedule dependency, and dose dependency of photons in wound healing. Fibroblast absorption and wound healing acceleration is maximal at 632.8 nm, indicating that the acceleration of wound healing is not credited to laser skin transmission. A HeNe laser at 632.8 nm with an incident power density of 10.53 mW/cm 2 gave the optimum wound healing acceleration, indicating the non-dose rate dependency of laser photons in enhancing wound healing. 20 proposed that LLLT inhibits conduction of nerve fibers, which was due to a reversible conformational change in the voltage-gated Na-K channels, similar to the action of local anesthetic agents. Studies conducted by De Souza 21 revealed that 75% of the study population reported reduction in pain immediately after a single session of laser treatment. Khademi et al 22 in a double-blind clinical trial treated 12 patients with minor RAS using a diode laser and reported that with the use of LLLT there was a decrease in the healing time and pain intensity in patients with aphthae.
INCREASE IN OXYGEN AVAILABILITY

LOW-LEVEL LASER THERAPY FOR RAS
LOW-LEVEL LASER THERAPY IN PERIODONTAL THERAPY
Chronic periodontal inflammation results in the destruction of periodontal ligament and leads to the loss of supporting periodontal tissues. Low-level laser therapy is reported to reduce gingival inflammation and expression of metalloproteinase 8 when used after scaling and root planning. Ozawa et al 23 reported that LLLT significantly inhibited increased plasminogen activity induced in human periodontal ligament cells in response to mechanical tensile force. Plasminogen activates latent collagenase, the enzyme, i.e., responsible for cleaving collagen fibers. Low-level laser therapy also has an effect on inhibition of PGE 2 synthesis. 24 Low-level laser therapy brings about modulation of the periodontal inflammatory process, especially through reduction of PGE 2 release. Gokce Aykol et al 25 showed that LLLT used as an adjunctive therapy to nonsurgical periodontal treatment improves periodontal healing. Amorim et al 26 used LLLT on gingivectomy wounds in 20 patients using a 685-nm laser with a power of 50 mW and energy density of 4 J/cm 2 . The authors observed a significant improvement in clinical parameters evaluated in the laser group at 21 and 28 days post surgery compared to the control sites. They postulated that the improvement is likely to be derived from higher collagen production leading to a better remodeling of connective tissue and a reduction of the probing depth, the latter in turn aiding oral hygiene and synergistically contributing to limiting inflammation.
A similar study by Ozcelik et al 27 showed that LLLT could enhance epithelialization and improve wound healing after gingivectomy and gingivoplasty procedures. Using a Mira-2-tone solution to visualize areas of epithelialization, the investigators treated patients with a 588-nm diode laser at 120 mW and 4 J/cm 2 for 7 days post surgery and observed a significant decrease in the non-epithelialized surfaces following LLLT, suggesting that besides stimulating collagen production, LLLT might also facilitate fibroblast and keratinocyte migration, angiogenesis, and growth factor release contributing to decreased inflammation and improved wound healing. Sanz-Moliner et al 28 studied 13 patients with generalized severe chronic periodontitis in which control sites were randomly selected to receive a Modified Widman Flap (MWF) surgery and the contralateral test sites an MWF surgery in conjunction with an 810-nm diode laser to de-epithelialize the inner part of the periodontal flap and photo-bio-stimulate the surgical area. They concluded that the use of an 810-nm diode laser provided additional benefits to MWF surgery in terms of less edema and postoperative pain.
LOW-LEVEL LASER THERAPY IN MAXILLOFACIAL REGION
Fikácková et al 29 conducted a study to investigate the effects of LLLT for pain caused by TMD in a controlled study comparing applied energy density, subgroups of TMD, and duration of disorders. The study group of 61 patients was treated with 10 or 15 J/cm 2 and the control group of 19 patients was treated with 0.1 J/cm 2 .
Low-level laser therapy was performed by a Gallium Aluminum Arsenide (GaAlAs) diode laser with an output of 400 mW and emitting radiation wavelength of 830 nm in 10 sessions. Changes in pain were evaluated by self-administered questionnaire. The results suggest that LLLT can be considered as a useful method for the treatment of TMD-related pain, especially long-lasting pain. In a systematic review by Marcello Melis et al 30 which
was performed according to the CONSORT 2010 criteria to evaluate the efficacy of LLLT for the treatment of TMD. A total of 14 articles were included in the review. Studies varied significantly in terms of methodological design, principally regarding the site of application of the laser, the number of applications performed, their duration, the laser beam features (wavelength, frequency, output, and dosage), and outcome measures. The only conclusion drawn was that LLLT is probably more effective for the treatment of TMD and less effective for the treatment of masticatory muscle disorders.
CONCLUSION
Low-level laser therapy offers an attractive, painless, and noninvasive therapeutic way to modulate inflammation in dentistry. Biostimulation is an evolving technology. More is being discovered about the mechanisms of lowlevel lasers as the day passes. Low-level laser therapy is a useful adjunctive treatment modality in various fields of dentistry. It has positive effects on both hard and soft tissues of the oral cavity and less antagonistic effects. It is clear that LLLT can encourage the behavior of various cell types and that several effects can occur at the same time.
The future prospects for LLLT are promising. Usefulness of the LLLT should also be discovered with respect to the wavelength, duration of treatment, and the site of application. Efforts should be focused toward inspecting the accurate dose required for therapeutic effects in order to achieve standardization of treatment protocols.
